Envestnet Portfolio Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
2,169
+398
| +22% | +$209K | ﹤0.01% | 747 |
|
|
2025
Q1 | $1.12M | Sell |
1,771
-913
| -34% | -$579K | ﹤0.01% | 756 |
|
|
2024
Q4 | $1.91M | Buy |
2,684
+713
| +36% | +$508K | 0.01% | 678 |
|
|
2024
Q3 | $2.07M | Buy |
1,971
+279
| +16% | +$293K | 0.01% | 649 |
|
|
2024
Q2 | $1.78M | Buy |
1,692
+104
| +7% | +$109K | 0.01% | 667 |
|
|
2024
Q1 | $1.53M | Buy |
1,588
+400
| +34% | +$385K | 0.01% | 716 |
|
|
2023
Q4 | $1.04M | Buy |
1,188
+370
| +45% | +$325K | ﹤0.01% | 785 |
|
|
2023
Q3 | $673K | Buy |
+818
| New | +$673K | ﹤0.01% | 865 |
|